HOSPITALIZATION AND EXACERBATION ESTIMATES OF EFGARTIGIMOD VS. CONVENTIONAL THERAPY IN GENERALIZED MYASTHENIA GRAVIS PATIENTS: A POST-HOC ANALYSIS OF THE PHASE 3 ADAPT STUDY

被引：0
|
作者：
Qi, C. [1 ]
Dewilde, S. [2 ]
Gelinas, D. [1 ]
Brauer, E. [1 ]
Phillips, G. [1 ]
机构：
[1] Argenx Inc, Boston, MA USA
[2] SHE, Brussels, Vbr, Belgium
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO135
引用
收藏
页码：S329 / S329
页数：1
相关论文
共 50 条
  • [21] The effect of cariprazine on patient engagement: Post-hoc analysis of a phase 3 study in patients with predominant negative symptoms of schizophrenia
    Laszlovszky, I.
    Dombi, Z. B.
    Balogh, A.
    Barabassy, A.
    Vass, G.
    Szatmari, B.
    Nemeth, G.
    EUROPEAN PSYCHIATRY, 2021, 64 : S533 - S533
  • [22] Impact of BMI on TTFields in Patients with Mnsclc: Post-hoc Analysis from the Phase 3 LUNAR Study and Simulation Model Data
    Rolfo, C.
    Gerber, D. E.
    Kotecha, R.
    Ward, J.
    Akerley, W.
    Naveh, A.
    Shapira, N.
    Leal, T.
    Langer, C.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S188 - S188
  • [23] Social and functional outcomes with two doses of aripiprazole lauroxil vs placebo in patients with schizophrenia: a post-hoc analysis of a 12-week phase 3 efficacy study
    Correll, Christoph U.
    Stanford, Arielle D.
    Claxton, Amy
    Du, Yangchun
    Weiden, Peter J.
    PSYCHIATRY RESEARCH, 2019, 274 : 176 - 181
  • [24] Concomitant Drug Load Reduction During Adjunctive Cenobamate Therapy: Post-hoc Analysis of a Phase 3, Open-Label Study
    Aboumatar, Sami
    Ferrari, Louis
    Stern, Sean
    Wade, Clarence
    Weingarten, Mindl
    Connor, Gregory S.
    Rosenfeld, William E.
    NEUROLOGY, 2023, 100 (17)
  • [25] Effects of safinamide adjunct therapy on non-motor symptoms in patients with Parkinson's disease: a post-hoc analysis of the Japanese Phase 2/3 study
    Hattori, N.
    Tsuboi, Y.
    Kogo, Y.
    Koebisu, M.
    Ishida, T.
    Suzuki, I.
    Nomoto, M.
    MOVEMENT DISORDERS, 2021, 36 : S174 - S175
  • [26] Single Inhaler Extrafine Triple Therapy Vs Indacaterol/Glycopyrronium in COPD Patients Previously Treated with LABA/LAMA: Post-Hoc Analysis of the Tribute Study
    Scuri, M.
    Singh, D.
    Fabbri, L. M.
    Valente, I.
    Guasconi, A.
    Vezzoli, S.
    Prunier, H.
    Cohuet, G.
    Muraro, A.
    Petruzzelli, S.
    Papi, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [27] Changes in Concomitant Immunosuppressive Therapy Use During a Phase 3 Open-label Study of Eculizumab in Adults with Generalized Myasthenia Gravis: an Interim Analysis
    Nowak, Richard J.
    Muppidi, Srikanth
    Beydoun, Said R.
    O'Brien, Fanny
    Yountz, Marcus
    Howard, James F.
    NEUROLOGY, 2019, 92 (15)
  • [28] Effect of daridorexant on patients with comorbid insomnia disorder and untreated mild obstructive sleep apnea: A post-hoc analysis of a phase 3 study
    Lettieri, Christopher
    Leger, Damien
    Luyet, Pierre-Philippe
    Malhotra, Atul
    Pepin, Jean-Louis
    Quan, Stuart Fun
    Raphelson, Janna
    Saskin, Paul
    Briasoulis, Orestis
    JOURNAL OF SLEEP RESEARCH, 2024, 33
  • [29] Post-hoc subgroup analysis of Asian subjects from the pivotal phase 3 study of once-weekly somatrogon vs once-daily Genotropin
    Gomez, Roy
    Khadilkar, Vaman
    Shembalkar, Jayashri
    Chu, Der-Ming
    Ko, Cheol Woo
    Wajnrajch, Michael
    Wang, Ronnie
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 283 - 284
  • [30] Reduction in Pain During and Between Attacks in Patients with Acute Hepatic Porphyria Treated with Givosiran: A Post-Hoc Analysis of the Phase 3 ENVISION Study
    Monroy, Susana
    Kauppinen, Raili
    Kuo, Hung-Chou
    Oh, Jeeyoung
    Hother-Nielson, Ole
    Fanelli, Mary-Jean
    Hua, Zhaowei
    He, Qiuling
    Ko, John J.
    Simon, Amy
    Rees, David
    NEUROLOGY, 2021, 96 (15)
12345